Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - MOTT DAVID M
Last Updated 
22-Jul-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

MOTT DAVID M: Declared Holdings
Company/RelationshipReportedShares  Ownership
Adaptimmune Therapeutics plc
Director
NasdaqGS:ADAP
(historical quotes, profile, other insiders)
1-Jan-1659,269,000  Indirect
Achaogen, Inc.
Beneficial Owner (10% or more)
NasdaqGM:AKAO
(historical quotes, profile, other insiders)
3-Jun-164,715,128  Indirect
Ardelyx, Inc.
Director
NasdaqGM:ARDX
(historical quotes, profile, other insiders)
2-Jun-16
18-Jul-16
14,343
   5,331,039
5,345,382
  Direct
  Indirect  
  Total
AVEO Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGS:AVEO
(historical quotes, profile, other insiders)
13-May-1610,362,694  Indirect
Box, Inc. Class A Common Stock
Beneficial Owner (10% or more)
NYSE:BOX
(historical quotes, profile, other insiders)
28-Jan-150  Indirect
CVENT, INC. Common Stock
Beneficial Owner (10% or more)
NYSE:CVT
(historical quotes, profile, other insiders)
25-Nov-143,994,610  Indirect
Dermira, Inc.
Beneficial Owner (10% or more)
NasdaqGS:DERM
(historical quotes, profile, other insiders)
8-Oct-143,502,922  Indirect
Epizyme, Inc.
Director
NasdaqGS:EPZM
(historical quotes, profile, other insiders)
1-Jul-16
12-Jan-16
6,000
   6,261,502
6,267,502
  Direct
  Indirect  
  Total
INTERLEUKIN GENETICS
Beneficial Owner (10% or more)
Other OTC:ILIU
(historical quotes, profile, other insiders)
23-Dec-1435,298,087  Indirect
Loxo Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGM:LOXO
(historical quotes, profile, other insiders)
6-Aug-141,789,420  Indirect
Mirna Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:MIRN
(historical quotes, profile, other insiders)
6-Oct-152,971,517  Indirect
TRACON Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:TCON
(historical quotes, profile, other insiders)
4-Feb-151,888,474  Indirect
TESARO, Inc.
Director
NasdaqGS:TSRO
(historical quotes, profile, other insiders)
1-Jun-16
18-Mar-16
12,149
   10,276,446
10,288,595
  Direct
  Indirect  
  Total

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
18-Jul-16 *1,527,301ARDX Purchase at $8.73 per share.
(Cost of $13,333,337)
1-Jul-16 6,000EPZM Acquisition (Non Open Market) at $10.33 per share.
(Value of $61,980)
3-Jun-16 *4,715,128AKAO Statement of Ownership
2-Jun-16 8,522ARDX Acquisition (Non Open Market) at $0 per share.
1-Jun-16 2,115TSRO Acquisition (Non Open Market) at $0 per share.
13-May-16 *10,362,694AVEO Statement of Ownership
18-Mar-16 *1,420,858TSRO Purchase at $35.19 - $35.19 per share.
(Cost of about $50,000,000)
13-Jan-16 *1,000,000ARDX Purchase at $10 per share.
(Cost of $10,000,000)
12-Jan-16 *1,111,111EPZM Purchase at $9 - $9 per share.
(Cost of about $10,000,000)
1-Jan-16 *59,269,000ADAP Statement of Ownership
6-Oct-15 *289,166MIRN Acquisition (Non Open Market) at $0 per share.
6-Oct-15 *857,142MIRN Purchase at $7 - $7 per share.
(Cost of about $6,000,000)
5-Oct-15 *1,825,209MIRN Acquisition (Non Open Market)
11-Jun-15 5,821ARDX Acquisition (Non Open Market) at $0 per share.
5-Jun-15 *2,803,738ARDX Purchase at $10.70 - $10.7 per share.
(Cost of about $30,000,000)
1-Jun-15 1,357TSRO Acquisition (Non Open Market) at $0 per share.
1-Jun-15 *1,010,000TSRO Disposition (Non Open Market) at $0 per share.
1-Jun-15 *10,504TSRO Acquisition (Non Open Market) at $0 per share.
4-Feb-15 *1,388,474TCON Acquisition (Non Open Market)
4-Feb-15 *500,000TCON Purchase at $10 - $10 per share.
(Cost of about $5,000,000)
28-Jan-15 *2,091,457BOX Disposition (Non Open Market)
28-Jan-15 *1,928,677BOX Acquisition (Non Open Market)
22-Jan-15 *162,780BOX Statement of Ownership
23-Dec-14 *19,868,965ILIU Purchase at $0.10 - $0.1 per share.
(Cost of about $1,987,000)
25-Nov-14 *1,010,000CVT Disposition (Non Open Market) at $0 per share.
25-Nov-14 *10,504CVT Acquisition (Non Open Market) at $0 per share.
8-Oct-14 *69,112DERM Purchase at $16 - $16 per share.
(Cost of about $1,106,000)
8-Oct-14 *3,416,569DERM Acquisition (Non Open Market) at $0 per share.
2-Oct-14 *17,241DERM Statement of Ownership
19-Aug-14 *505CVT Sale at $26.52 - $26.52 per share.
(Proceeds of about $13,000)
14-Aug-14 *1,302,900EPZM Disposition (Non Open Market) at $0 per share.
14-Aug-14 *13,551EPZM Acquisition (Non Open Market) at $0 per share.
14-Aug-14 *1,010,000CVT Disposition (Non Open Market) at $0 per share.
14-Aug-14 *10,505CVT Acquisition (Non Open Market) at $0 per share.
6-Aug-14 *1,558,651LOXO Acquisition (Non Open Market)
6-Aug-14 *230,769LOXO Purchase at $13 - $13 per share.
(Cost of about $3,000,000)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?